Dianthus Therapeutics grants 52,000 inducement stock options at $106.62 each
DNTH•Inducement stock options granted to new hires
Dianthus Therapeutics granted inducement stock options covering 52,000 shares to four newly hired non-executive employees on Sept. 1, 2026.
The options carry a 10-year term with an exercise price of $106.62 per share.
Vesting starts with 25% after one year, then continues in equal monthly installments over the next 36 months.
The awards were issued under the company’s Equity Inducement Plan and a stock option agreement.
